Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice.
作者信息
Fouquet G, Franchi P, Mittaine-Marzac B, Laporte N, Ihaddadene H, Decroocq J, Breal C, Bouscary D, Ammar F, Zogo A, Burgun S, Zerbit J, Willems L, Deau-Fischer B, Vignon M
机构信息
Hematology Department, Cochin Hospital, APHP, Paris, France.
Hospital At Home, APHP, Paris, France.
出版信息
Support Care Cancer. 2022 Feb;30(2):973-975. doi: 10.1007/s00520-021-06297-4. Epub 2021 May 31.
Abstract
摘要
相似文献
1
Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice.
Support Care Cancer. 2022 Feb;30(2):973-975. doi: 10.1007/s00520-021-06297-4. Epub 2021 May 31.
2
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.
Eur J Haematol. 2020 Nov;105(5):662-666. doi: 10.1111/ejh.13479. Epub 2020 Jul 15.
3
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Korean J Intern Med. 2021 Nov;36(6):1459-1470. doi: 10.3904/kjim.2021.186. Epub 2021 Oct 21.
4
Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center.
Rev Invest Clin. 2022 Jan 3;74(1):16-22. doi: 10.24875/RIC.21000347.
5
Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period.
Leukemia. 2022 Aug;36(8):2136-2139. doi: 10.1038/s41375-022-01633-x. Epub 2022 Jun 27.
6
Multiple Myeloma in the Time of COVID-19.
Acta Haematol. 2020;143(5):410-416. doi: 10.1159/000507690. Epub 2020 Apr 17.
7
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
Blood Cancer J. 2023 Mar 15;13(1):38. doi: 10.1038/s41408-023-00795-w.
8
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).
Br J Haematol. 2021 Mar;192(6):e136-e139. doi: 10.1111/bjh.17261. Epub 2020 Dec 16.
9
Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
J Med Case Rep. 2021 Feb 19;15(1):90. doi: 10.1186/s13256-020-02598-0.
10
Don't Compromise Myeloma Care Due to COVID-19 Pandemic!
Blood Cancer Discov. 2020 Oct 13;1(3):218-220. doi: 10.1158/2643-3230.BCD-20-0151. eCollection 2020 Nov.
引用本文的文献
1
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.
Clin Exp Med. 2025 May 27;25(1):179. doi: 10.1007/s10238-025-01683-2.
2
Navigating uncharted waters: assessing the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation: challenges and innovations.
Ann Med Surg (Lond). 2024 Aug 7;86(9):5416-5424. doi: 10.1097/MS9.0000000000002442. eCollection 2024 Sep.
3
Influences of COVID-19 pandemic on hospital-at-home functions in Finland - a questionnaire survey.
Scand J Prim Health Care. 2022 Sep;40(3):379-384. doi: 10.1080/02813432.2022.2139475. Epub 2022 Nov 3.
Zotero 插件